Last reviewed · How we verify
Low dose oxelidine group
Low dose oxelidine group is a Monoamine oxidase inhibitor Small molecule drug developed by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. It is currently FDA-approved for Depression.
Low-dose oxelidine acts as a monoamine oxidase inhibitor to increase neurotransmitter levels in the central nervous system.
Low-dose oxelidine acts as a monoamine oxidase inhibitor to increase neurotransmitter levels in the central nervous system. Used for Depression, Cognitive impairment.
At a glance
| Generic name | Low dose oxelidine group |
|---|---|
| Sponsor | The Fourth Affiliated Hospital of Zhejiang University School of Medicine |
| Drug class | Monoamine oxidase inhibitor |
| Target | Monoamine oxidase |
| Modality | Small molecule |
| Therapeutic area | Psychiatry/Neurology |
| Phase | FDA-approved |
Mechanism of action
Oxelidine is a reversible monoamine oxidase (MAO) inhibitor that increases the availability of monoamines such as serotonin, norepinephrine, and dopamine by blocking their enzymatic degradation. At low doses, this mechanism is intended to provide therapeutic benefit while minimizing the risk of hypertensive crisis and other adverse effects associated with higher-dose MAO inhibitor therapy.
Approved indications
- Depression
Common side effects
- Hypertension
- Insomnia
- Dizziness
- Headache
Key clinical trials
- Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Low dose oxelidine group CI brief — competitive landscape report
- Low dose oxelidine group updates RSS · CI watch RSS
- The Fourth Affiliated Hospital of Zhejiang University School of Medicine portfolio CI
Frequently asked questions about Low dose oxelidine group
What is Low dose oxelidine group?
How does Low dose oxelidine group work?
What is Low dose oxelidine group used for?
Who makes Low dose oxelidine group?
What drug class is Low dose oxelidine group in?
What development phase is Low dose oxelidine group in?
What are the side effects of Low dose oxelidine group?
What does Low dose oxelidine group target?
Related
- Drug class: All Monoamine oxidase inhibitor drugs
- Target: All drugs targeting Monoamine oxidase
- Manufacturer: The Fourth Affiliated Hospital of Zhejiang University School of Medicine — full pipeline
- Therapeutic area: All drugs in Psychiatry/Neurology
- Indication: Drugs for Depression
- Compare: Low dose oxelidine group vs similar drugs
- Pricing: Low dose oxelidine group cost, discount & access